Business, energy, technology, markets and global industry news from Business News Today

radioligand therapy

PharmaDeviceNews radioligand therapy
Representative image: A nuclear medicine clinician monitors intravenous radiopharmaceutical administration, reflecting Radnostix’s acquisition of Lucerno Dynamics assets and its expansion into real-time extravasation monitoring, dosimetry and radioligand therapy workflows.
Medical Devices & Diagnostics

Lucerno Dynamics asset deal gives Radnostix new route into nuclear medicine workflows

Discover how Radnostix’s Lucerno Dynamics deal could reshape radiopharmaceutical monitoring, dosimetry and theranostics delivery.

Read More
Representative image of radioligand therapy research for cancer-associated bone disease, highlighting how LIFT and NorthStar’s Lu-177-LT17 collaboration could advance targeted oncology treatment for bone lesions.
Pharma & Biotech

Can LIFT and NorthStar move Lu-177-LT17 into the next radioligand therapy frontier?

Find out how LIFT and NorthStar’s Lu-177-LT17 partnership could advance radioligand therapy for cancer bone disease today!

Read More
Representative image: A modern radioligand therapy manufacturing centre under construction in Texas, highlighting Novartis AG’s investment in U.S. oncology infrastructure and the growing race to scale precision cancer treatment supply chains.
Medical Devices & Diagnostics

Novartis bets on Texas as radioligand therapy moves closer to mainstream oncology

RLT demand is rising faster than supply chains can stretch. Novartis’ Texas buildout tests whether precision oncology can scale.

Read More